Compare SUPN & CVCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SUPN | CVCO |
|---|---|---|
| Founded | 2005 | 1965 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Homebuilding |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 3.5B |
| IPO Year | 2010 | 1994 |
| Metric | SUPN | CVCO |
|---|---|---|
| Price | $44.42 | $599.56 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 1 |
| Target Price | $61.60 | ★ $550.00 |
| AVG Volume (30 Days) | ★ 535.7K | 134.5K |
| Earning Date | 05-05-2026 | 05-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 15.79 |
| EPS | N/A | ★ 23.98 |
| Revenue | $392,755,000.00 | ★ $2,142,713,000.00 |
| Revenue This Year | $22.70 | $14.66 |
| Revenue Next Year | $19.14 | $7.70 |
| P/E Ratio | ★ N/A | $24.44 |
| Revenue Growth | N/A | ★ 31.68 |
| 52 Week Low | $31.16 | $395.37 |
| 52 Week High | $59.68 | $713.01 |
| Indicator | SUPN | CVCO |
|---|---|---|
| Relative Strength Index (RSI) | 38.79 | 66.80 |
| Support Level | $43.67 | $543.52 |
| Resistance Level | $52.36 | $604.08 |
| Average True Range (ATR) | 1.41 | 22.16 |
| MACD | -0.01 | 4.00 |
| Stochastic Oscillator | 41.04 | 83.62 |
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.
Cavco Industries Inc designs and produces factory-built homes under the Cavco Homes, Fleetwood Homes, and Palm Harbor Homes brands. It also produces modular homes, park model homes, and vacation cabins, as well as commercial structures, among others. The company operates principally in two segments: Factory-built housing, which includes wholesale and retail systems-built housing operations, and the Financial services segment, which includes manufactured housing consumer finance and insurance. Cavco receives a majority of its revenue from the Factory-built housing segment.